Downregulation of NKG2DLs by TGF-β in human lung cancer cells

Differential effects of histone deacetylases on the expression of nkg2d ligands and nk cell-mediated anticancer immunity in lung cancer cells

An inhibitor of programmed death ligand 1 enhances natural killer cell-mediated immunity against malignant melanoma cells

Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery

Upregulation of Myc promotes the evasion of NK cell-mediated immunity through suppression of NKG2D ligands in K562 cells

Cancer upregulated gene 2 (CUG2), a novel oncogene, promotes sternness-like properties via the NPM1-TGF-beta signaling axis

The Combination of Ionizing Radiation and Proteasomal Inhibition by Bortezomib Enhances the Expression of NKG2D Ligands in Multiple Myeloma Cells

Expansion of cytotoxic natural killer cells using irradiated autologous peripheral blood mononuclear cells and anti-CD16 antibody

Identification of tumor antigens in malignant mesothelioma

A cancer/testis antigen, NY-SAR-35, induces EpCAM, CD44, and CD133, and activates ERK in HEK293 cells